Key Takeaways
- Baba, an applied AI company, announced a $40 million Series A on October 20, 2026.
- Baba's Series A was led by FirstMark Capital, with CVS Health Ventures and Valtruis participating and three returning investors.
- Baba's $40 million Series A is one-third larger than Healthleap's $30 million Series A, the only other 2026 Series A in WYDE's startup directory.
- Baba says it has supported more than 10,000 patients, with 100,000 families on its waiting list.
Baba, an applied AI company that connects Medicare and Medicaid patients to care teams, announced a $40 million Series A led by FirstMark Capital on October 20, 2026. CVS Health Ventures and Valtruis also participated. The round is one-third larger than the Healthleap Series A that TechCrunch reported in October, the only other 2026 Series A in WYDE's startup directory.
Who Invested in Baba's $40 Million Series A
A Series A is a venture capital round that usually follows a seed round. Baba's release names six investors. Besides FirstMark Capital, which led the round, CVS Health Ventures and Valtruis participated, and General Catalyst, Genius Ventures and Ground Up Ventures returned as investors. The release says Baba will use the funding to advance its AI research, serve more health plans and accelerate its value-based arrangements. Value-based arrangements are payment contracts tied to patient outcomes and costs rather than to each service delivered.
In a statement quoted by Fierce Healthcare, Rick Heitzmann, a FirstMark Capital co-founder and partner, said: "They've proven that AI can finally bring Medicare patients and families the coordinated, concierge-level care they've always deserved."
How Baba's $40 Million Series A Compares With Healthleap's Series A
The round is one-third larger than the Healthleap Series A that TechCrunch reported in October. Healthleap is an AI platform that reads patient records to identify patients at risk of undiagnosed illnesses. TechCrunch reported on October 7, 2026 that Healthleap raised a $30 million Series A led by Hummingbird Ventures, alongside an $8 million seed round. WYDE covered that funding in Healthleap Raises $38 Million for AI That Flags Hospital Patients.
WYDE's startup directory lists impact startups and their funding rounds. In that directory, Healthleap's $30 million Series A, dated October 7, 2026, is the only other Series A dated 2026. Dividing $40 million by $30 million gives 1.33, so Baba's round is one-third larger. The comparison covers Series A rounds only.
What Baba's Series A Means for Medicare and Medicaid Patient Navigation
Connor Sweeney, founder and CEO of Baba, said: "By dramatically lowering the cost of operating and coordinating care, we have an opportunity to make care delivery economically viable for populations that have historically been too expensive to serve." The release says nearly 70 million Americans have Medicare, and that the number of specialists the average Medicare patient sees each year rose more than 40% over two decades. The release's summary says the funding will expand Baba's clinical care teams, advance its AI research and grow partnerships with health plans.
In the Fierce Healthcare interview, Sweeney said: "Our biggest focus is deepening our work with payers on value-based arrangements." He added that the company is continuing to build toward a model where it takes on risk. The stated uses point toward health plans and clinical staff. Related WYDE coverage: Abby Care Raises $82 Million to Train and Pay Family Members as Medicaid Caregivers.
The patient and waiting-list counts are executive figures. Fierce Healthcare attributes them to executives.
People Also Ask
How much did Baba raise in its Series A?
Baba raised $40 million in a Series A round that it announced on October 20, 2026. FirstMark Capital led the round, with CVS Health Ventures and Valtruis participating.
What does Baba do?
Baba is an applied AI company that connects Medicare and Medicaid patients to dedicated care teams, including care coordinators and licensed therapists, according to Fierce Healthcare. Founder and CEO Connor Sweeney says the company brings together providers, care coordinators, licensed therapists and AI.
Who founded Baba?
Connor Sweeney is the founder and CEO of Baba. Fierce Healthcare reported that Baba was founded in 2025.
How many patients has Baba supported?
Baba's executives say the company has supported more than 10,000 patients, with 100,000 families on its waiting list. Fierce Healthcare attributes those counts to the executives.
Sources: GlobeNewswire, Fierce Healthcare, TechCrunch.